Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Kailera Therapeutics
Biotech
Biotech's top money raisers: 2025
While 2024 marked the return of the biotech megaround, 2025 proved that it wasn’t just a one-year anomaly.
Gabrielle Masson
Mar 2, 2026 6:30am
PitchBook expects disciplined biopharma VC recovery in 2026
Feb 16, 2026 12:01am
Kailera, Hengrui to advance oral obesity drug into 2 new trials
Feb 10, 2026 9:25am
Kailera raises hefty $600M to take Zepbound rival into ph. 3
Oct 14, 2025 9:20am
Hengrui's GLP-1/GIP agonist posts 18% weight loss in ph. 3 trial
Jul 15, 2025 9:17am
A look at biotech's biggest money raisers of 2024
Mar 7, 2025 9:00am
